Current status of stem cells in cardiac repair

Robert J Henning1

  • 1Department of Environmental & Occupational Health, College of Public Health, University of South Florida & the James A Haley Hospital, Tampa, FL 33612-3805, USA.

Future Cardiology
|February 7, 2018
PubMed

Insights

Acute myocardial infarction (AMI) and congestive heart failure (CHF) affect millions. This review explores stem cell therapies, including embryonic, cardiac, bone marrow, and mesenchymal stem cells, as innovative treatments for these prevalent heart conditions.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • High lifetime incidence of acute myocardial infarction (AMI) affects men and women over 40.
  • Increased survival post-AMI leads to a rising prevalence of congestive heart failure (CHF).
  • Millions in the USA suffer from ischemic cardiomyopathies and CHF, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To review current stem cell investigations for treating AMI and CHF.
  • To examine the therapeutic potential of various stem cell types and their derivatives.

Main Methods:

  • Review of current scientific literature on stem cell applications in cardiology.
  • Analysis of studies involving human embryonic stem cells, cardiac stem/progenitor cells, bone marrow-derived mononuclear cells, and mesenchymal stem cells.
  • Inclusion of research on stem cell paracrine factors and exosomes.

Main Results:

  • Ongoing investigations explore diverse stem cell sources for cardiac repair.
  • Stem cell paracrine factors and exosomes are emerging as potential therapeutic agents.

Conclusions:

  • Stem cell-based therapies show promise for treating acute myocardial infarction and congestive heart failure.
  • Further research into stem cell paracrine factors and exosomes is warranted for novel treatment strategies.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
43.8K
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
34.0K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.7K
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
26.5K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
41.0K